CLOROX COMPANY (CLX) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:CLX - US1890541097 - Common Stock
109.98 USD
-1.25 (-1.12%)
109.98 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.389B 3.97% | 7.093B -4.01% | 7.104B 0.16% | 6.558B -7.69% | 6.873B 4.80% | 7.073B 2.91% | 7.292B 3.10% | 7.52B 3.13% | 7.943B 5.63% | 8.255B 3.93% | 8.586B 4.01% | |
| EBITDA YoY % growth | 1.048B 11.97% | 1.156B 10.31% | 1.404B 21.45% | 1.28B -8.83% | 1.416B 10.63% | 1.482B 4.66% | 1.562B 5.40% | 1.628B 4.23% | 1.759B 8.05% | 1.837B 4.43% | 1.919B 4.46% | |
| EBIT YoY % growth | 812M 14.04% | 921M 13.42% | 1.185B 28.66% | 1.063B -10.30% | 1.2B 12.89% | 1.277B 6.42% | 1.353B 5.95% | 1.416B 4.66% | 1.522B 7.49% | 1.591B 4.53% | 1.663B 4.53% | |
| Operating Margin | 10.99% | 12.98% | 16.68% | 16.21% | 17.46% | 18.05% | 18.55% | 18.83% | 19.16% | 19.27% | 19.37% | |
| EPS YoY % growth | 5.09 23.84% | 6.18 21.41% | 7.73 25.08% | 5.99 -22.50% | 6.82 13.90% | 7.23 5.88% | 7.83 8.36% | 8.27 5.62% | 9.00 8.82% | 9.62 6.85% | 10.27 6.83% |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.47 -5.35% | 1.60 10.01% | 2.04 -28.77% | 1.41 65.75% | 1.62 10.41% | 1.71 7.40% | 2.17 5.99% | 1.59 12.55% | 1.71 5.80% | 1.79 4.74% | 2.33 7.67% |
| Revenue Q2Q % growth | 1.66B -1.54% | 1.686B 1.08% | 1.767B -11.12% | 1.634B 14.35% | 1.704B 2.65% | 1.725B 2.31% | 1.812B 2.55% | 1.721B 5.32% | 1.761B 3.35% | 1.772B 2.72% | 1.884B 3.97% |
| EBITDA Q2Q % growth | 315.83M -7.38% | 336.36M -16.74% | 417.19M -35.92% | 301.99M 72.57% | 335.06M 6.09% | 348.13M 3.50% | 430.97M 3.30% | 328.25M 8.70% | 350.2M 4.52% | 353.68M 1.59% | 452.02M 4.88% |
| EBIT Q2Q % growth | 261.18M 11.62% | 281.82M 16.45% | 363.22M -15.92% | 249.1M 109.33% | 281.63M 7.83% | 296.12M 5.07% | 379.51M 4.48% | 279.58M 12.24% | 302.06M 7.25% | 304.83M 2.94% | 401.38M 5.76% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | 0.85 -54.30% | 0.79 | 0.06 | 6.97% |
| Q4 2025 Q2Q % growth | 2.87 57.69% | 2.23 | 0.64 | 28.70% |
| Q3 2025 Q2Q % growth | 1.45 -15.20% | 1.58 | -0.13 | -8.29% |
| Q2 2025 Q2Q % growth | 1.55 -28.24% | 1.42 | 0.13 | 9.12% |
| Q1 2025 Q2Q % growth | 1.86 279.59% | 1.41 | 0.45 | 32.02% |
| Q4 2024 Q2Q % growth | 1.82 8.98% | 1.58 | 0.24 | 15.42% |
| Q3 2024 Q2Q % growth | 1.71 13.25% | 1.38 | 0.33 | 23.77% |
| Q2 2024 Q2Q % growth | 2.16 120.41% | 1.11 | 1.05 | 94.70% |
| Q1 2024 Q2Q % growth | 0.49 -47.31% | -0.22 | 0.71 | 320.59% |
| Q4 2023 Q2Q % growth | 1.67 79.57% | 1.20 | 0.47 | 39.73% |
| Q3 2023 Q2Q % growth | 1.51 15.27% | 1.24 | 0.27 | 22.24% |
| Q2 2023 Q2Q % growth | 0.98 48.48% | 0.65 | 0.33 | 49.71% |
| Q1 2023 Q2Q % growth | 0.93 -23.14% | 0.75 | 0.18 | 23.91% |
| Q4 2022 Q2Q % growth | 0.93 -2.11% | 0.94 | -0.01 | -0.93% |
| Q3 2022 Q2Q % growth | 1.31 -19.14% | 0.98 | 0.33 | 33.25% |
| Q2 2022 Q2Q % growth | 0.66 -67.49% | 0.85 | -0.19 | -22.45% |
| Q1 2022 Q2Q % growth | 1.21 -62.42% | 1.04 | 0.17 | 16.09% |
| Q4 2021 Q2Q % growth | 0.95 -60.58% | 1.37 | -0.42 | -30.43% |
| Q3 2021 Q2Q % growth | 1.62 -14.29% | 1.49 | 0.13 | 8.50% |
| Q2 2021 Q2Q % growth | 2.03 39.04% | 1.80 | 0.23 | 12.65% |
| Q1 2021 Q2Q % growth | 3.22 102.52% | 2.35 | 0.87 | 37.29% |
| Q4 2020 Q2Q % growth | 2.41 | 2.01 | 0.40 | 19.66% |
| Q3 2020 Q2Q % growth | 1.89 | 1.68 | 0.21 | 12.24% |
| Q2 2020 Q2Q % growth | 1.46 | 1.33 | 0.13 | 10.05% |
| Q1 2020 Q2Q % growth | 1.59 | 1.56 | 0.03 | 2.14% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2026 Q2Q % growth | 1.429B -18.90% | 1.414B | 15M | 1.06% |
| Q4 2025 Q2Q % growth | 1.988B 4.47% | 1.957B | 31M | 1.58% |
| Q3 2025 Q2Q % growth | 1.668B -8.05% | 1.743B | -75M | -4.30% |
| Q2 2025 Q2Q % growth | 1.686B -15.28% | 1.643B | 43M | 2.62% |
| Q1 2025 Q2Q % growth | 1.762B 27.13% | 1.659B | 103M | 6.21% |
| Q4 2024 Q2Q % growth | 1.903B -5.75% | 1.971B | -68M | -3.45% |
| Q3 2024 Q2Q % growth | 1.814B -5.27% | 1.888B | -74M | -3.92% |
| Q2 2024 Q2Q % growth | 1.99B 16.03% | 1.822B | 168M | 9.22% |
| Q1 2024 Q2Q % growth | 1.386B -20.34% | 1.32B | 66M | 5.00% |
| Q4 2023 Q2Q % growth | 2.019B 12.10% | 1.895B | 124M | 6.54% |
| Q3 2023 Q2Q % growth | 1.915B 5.86% | 1.836B | 79M | 4.30% |
| Q2 2023 Q2Q % growth | 1.715B 1.42% | 1.674B | 41M | 2.45% |
| Q1 2023 Q2Q % growth | 1.74B -3.65% | 1.71B | 30M | 1.75% |
| Q4 2022 Q2Q % growth | 1.801B -0.06% | 1.879B | -78M | -4.15% |
| Q3 2022 Q2Q % growth | 1.809B 1.57% | 1.812B | -3M | -0.17% |
| Q2 2022 Q2Q % growth | 1.691B -8.20% | 1.681B | 10M | 0.59% |
| Q1 2022 Q2Q % growth | 1.806B -5.74% | 1.714B | 92M | 5.37% |
| Q4 2021 Q2Q % growth | 1.802B -9.13% | 1.94B | -138M | -7.11% |
| Q3 2021 Q2Q % growth | 1.781B -0.11% | 1.885B | -104M | -5.52% |
| Q2 2021 Q2Q % growth | 1.842B 27.12% | 1.767B | 75M | 4.24% |
| Q1 2021 Q2Q % growth | 1.916B 27.22% | 1.772B | 144M | 8.13% |
| Q4 2020 Q2Q % growth | 1.983B | 1.893B | 90M | 4.75% |
| Q3 2020 Q2Q % growth | 1.783B | 1.727B | 56M | 3.24% |
| Q2 2020 Q2Q % growth | 1.449B | 1.445B | 4M | 0.28% |
| Q1 2020 Q2Q % growth | 1.506B | 1.527B | -21M | -1.38% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -4.61% | 0.07% | -2.63% |
| Revenue | 0% | -0.66% | -0.03% | -0.26% |